Rita Balsano

8PUBLICATIONS
57CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 24, 2026
Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

|Jan 09, 2024
Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study.

Ingrid Garajová, Annalisa Comandatore, Lenka Boyd

|May 15, 2023
Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights.

Rita Balsano, Valentina Zanuso, Angelo Pirozzi

|Dec 11, 2022
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?

Chiara Tommasi, Rita Balsano, Matilde Corianò

|Oct 27, 2022
Olaparib as a single agent treatment in pre-treated metastatic pancreatic cancer patient harboring BRCA2 mutation: What could we expect?

Ingrid Garajová, Rita Balsano, Fabio Gelsomino

|Sep 09, 2022
Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics.

Rita Balsano, Zita Kruize, Martina Lunardi

Pageof 2

Frequent Collaborators

3 joint publications

Annalisa Comandatore

3 joint publications

Elisa Giovannetti

3 joint publications

Luca Morelli

2 joint publications

Ingrid Garajová